7,8-Didehydrocimigenol
7,8-Didehydrocimigenol can be used for the treatment of cardiovascular disorders such as atherosclerosis. It upregulates PPAR-γ in EC inhibits NF-kB activity of TNF-α-activated EC which leads to selective inhibition of VCAM-1 expression.
| Catalog Number | TN3219 |
| Research Area | PI3K/Akt/mTOR signaling|||MAPK|||NF-Κb|||Apoptosis|||Metabolism|||Cytoskeletal Signaling|||DNA Damage/DNA Repair |
| Molecular Formula | C30H46O5 |
| CAS# | 150972-72-8 |
| SMILES | [H][C@]12[C@H](C)C[C@H]3O[C@@]1(O[C@@H]3C(C)(C)O)[C@H](O)[C@@]1(C)C3=CC[C@]4([H])[C@]5(C[C@@]35CC[C@]21C)CC[C@H](O)C4(C)C |t:20| |
| Size | 5 mg |
| Supplier Page | https://www.targetmol.com/compound/7,8-Didehydrocimigenol |
| Additional Information | https://www.targetmol.com/datasheet/TN3219 |